For example: Apple Inc, UTIL, Aluminum
Globus Medical Inc
NYSE:GMED
Market Close 08/16
49.75 USD +1.04 (+2.14%)
OPEN:
48.76
DAY RANGE:
48.56 - 50.02
PE:
28.97
PB:
3.60
PS:
5.64
WTD % 1.18
MTD % 9.15
QTD % 17.61
YTD % 14.95
* Updated at market close
Globus Medical Inc (NYSE:GMED) opened on Aug 16, 2019 at 48.76 USD and gained nearly 2.14%. The intraday price range was 48.56 - 50.02 USD and eventually ended the session at 49.75 USD. The stock trade volume was 649,100.00 shares. The company's 52-week range is 38.01 - 57.83 USD.
Trading Statistics (Market Close Aug 16, 2019)
Market Cap 4.92 B
Outstanding Stock 98.48 M
Dividend 0.00
Dividend Yield 0.00
EPS 1.46
YTD Change 14.95%
52 Week's Range 38.01 - 57.83
Key Ratio & Margins (Market Close Aug 16, 2019)
Price/Earning 28.97
Price/Book Value 3.60
Price/Sales 5.64
ROA 12.90%
ROE 14.10%
Debt/Equity 0.08
Company Self Description
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address an array of spinal pathologies, anatomies, and surgical approaches. Its fusion products include a range of implant and surgical approach options to treat degenerative, deformity, tumor, and trauma conditions along the spine from the occiput to the sacrum. It was founded in 2003 and is headquartered in Audubon, Pennsylvania, United States.
Business Information
Globus Medical Inc
Sector Health Care
Industry Health Care Equipment & Supplies
Exchange NYSE
Top Competitors (Market Close Aug 16, 2019)
  GMED PEN IART LIVN
Daily Change (%) 2.14 -0.03 1.65 2.50
WTD (%) 1.18 -1.59 -2.83 -3.36
MTD (%) 9.15 -13.36 -3.74 3.13
QTD (%) 17.61 -9.24 9.26 10.42
YTD (%) 14.95 18.83 35.30 -13.13
52-Week Change (%) -5.08 13.18 2.42 -34.87
Stock Performance (Market Close Aug 16, 2019)
  GMED PEN IART LIVN
Daily Change (%) 2.14 -0.03 1.65 2.50
WTD (%) 1.18 -1.59 -2.83 -3.36
MTD (%) 9.15 -13.36 -3.74 3.13
QTD (%) 17.61 -9.24 9.26 10.42
YTD (%) 14.95 18.83 35.30 -13.13
52-Week Change (%) -5.08 13.18 2.42 -34.87
Key Fundamentals (Market Close Aug 16, 2019)
  GMED PEN IART LIVN
Market Cap 4.92 B 5.04 B 5.22 B 3.84 B
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin 19.30% 3.00% 6.80% -23.90%
P/E Ratio 28.97 372.09 46.93 -13.30
Price to Sales Ratio 5.64 11.21 3.20 3.17
Price to Book Ratio 3.60 9.99 2.79 2.96
Enterprise Value to EBITDA 18.98 498.27 21.77 -25.27
ROA 12.90% 2.80% 3.20% -10.10%
ROE 14.10% 3.50% 7.30% -16.70%
Debt/Equity 0.08 0.22 1.26 0.70
Asset Turnover Ratio 0.56 0.91 0.47 0.42
Current Ratio 6.56 6.22 2.95 1.07
Dividend Yield 0.00 0 0 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 712.97 M 635.98 M 563.99 M 544.75 M
Cost Of Revenue 159.41 M 150.45 M 134.71 M 132.33 M
Gross Profit 553.56 M 485.52 M 429.29 M 412.42 M
Selling General & Administrative Expenses 311.59 M 267.82 M 222.16 M 210.24 M
Research & Development 55.50 M 43.68 M 44.53 M 36.31 M
Operating Income 169.33 M 161.84 M 154.14 M 172.22 M
Net Income 156.47 M 107.35 M 104.34 M 112.78 M
EPS 1.60 1.12 1.09 1.19
Diluted EPS 1.54 1.10 1.08 1.17
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 194.54 M 182.95 M 195.94 M 169.24 M
Cost Of Revenue 43.99 M 41.84 M 45.95 M 37.85 M
Gross Profit 150.55 M 141.11 M 149.98 M 131.39 M
Selling General & Administrative Expenses 88.38 M 85.78 M 83.64 M 75.13 M
Research & Development 15.75 M 14.32 M 13.76 M 15.53 M
Operating Income 42.87 M 37.08 M 43.25 M 38.30 M
Net Income 38.16 M 33.21 M 36.75 M 35.21 M
EPS 0.39 0.34 0.37 0.36
Diluted EPS 0.38 0.33 0.36 0.35
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 630.68 M 620.34 M 513.77 M 544.80 M
Cash & Cash Equivalents 139.75 M 118.82 M 67.43 M 86.27 M
Total Assets 1.30 B 1.08 B 927.64 M 834.10 M
Total Current Liabilities 96.12 M 93.07 M 79.89 M 82.69 M
Total Liabilities 115.15 M 110.72 M 95.56 M 118.78 M
Shareholder's Equity 1.19 B 967.78 M 832.08 M 715.32 M
Outstanding Stock 98.48 M 96.38 M 95.83 M 95.24 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 583.93 M 617.57 M 630.68 M 646.40 M
Cash & Cash Equivalents 117.79 M 129.98 M 139.75 M 145.30 M
Total Assets 1.39 B 1.34 B 1.30 B 1.24 B
Total Current Liabilities 84.18 M 79.49 M 96.12 M 81.72 M
Total Liabilities 103.22 M 98.71 M 115.15 M 97.39 M
Shareholder's Equity 1.29 B 1.24 B 1.19 B 1.14 B
Outstanding Stock 98.99 M 98.65 M 98.48 M 98.25 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations 181.64 M 159.06 M 147.82 M 124.01 M
Capital Expenditures -59.70 M -51.30 M -40.91 M -50.76 M
Net Cash Flow from Investing Activities -193.03 M -111.28 M -162.74 M -153.05 M
Net Cash Flow from Financial Activities 32.57 M 1.63 M 470,000.00 4.28 M
Free Cash Flow 121.95 M 107.76 M 106.91 M 73.25 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations 22.60 M 159.06 M 147.82 M 124.01 M
Capital Expenditures -14.74 M -28.16 M -17.16 M -15.37 M
Net Cash Flow from Investing Activities -36.74 M -53.84 M -52.62 M -28.86 M
Net Cash Flow from Financial Activities 1.73 M 4.91 M 2.84 M 2.55 M
Free Cash Flow 7.86 M 11.05 M 27.13 M 36.42 M
Key Ratios (Market Close Aug 16, 2019)
Valuation Ratios 2019 2018 2017 2016
P/E Ratio 28.97 32.29 27.05 38.09
Price to Sales Ratio 5.64 6.76 5.94 8.05
Price to Book Ratio 3.60 4.09 2.86 3.70
Enterprise Value to EBIT 23.00 23.00 15.00 15.00
Enterprise Value to EBITDA 18.98 18.53 11.85 13.07
Profitability Ratios 2019 2018 2017 2016
Revenue Growth - - - -
Net Income Growth - - - -
ROA 12.90% 12.90% 10.50% 11.80%
ROE 14.10% 14.10% 11.70% 13.20%
Liquidity Ratios 2019 2018 2017 2016
Working Capital 534.56 M 527.27 M 433.87 M 462.11 M
Current Ratio 6.56 6.67 6.43 6.59
Efficiency & Capital Structure Ratios 2019 2018 2017 2016
Debt Equity Ratio 0.08 0.11 0.12 0.17
Asset Turnover Ratio 0.59 0.59 0.63 0.64
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.